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 Frankenstein set out to create a superior human being in a time when there was very little 
knowledge about the human body and its genetic makeup. In piecing different parts of human 
and animal bodies together, Frankenstein believed that his creation would be a beautiful being 
with extraordinary physical and mental abilities. Victor did not take into consideration the effect 
that his creation would have on the society and this is what inevitably led to the horrors which 
occurred after the night of his creation. Victor himself did not even fully understand what he was 
creating and due to this he was the first to reject his “child” and push him towards a horrible life 
full of discrimination and foul treatment. These horrors which are seen in the novel Frankenstein 
are starting to become all too real in the new era of scientific advancement, and if proper caution 
is not taken the effects could be quite dangerous.  
 Genome editing, also known as gene editing, is a group of technologies which allow 
genetic material to be added to, removed, or changed at specific locations in an organism’s 
genome. There have been different technological developments in genome editing before 
CRISPR, but with each new advancement, the efficiency and specificity have increased therefore 
phasing the old technologies out. CRISPR-Cas9, short for clustered regularly interspaced short 
palindromic repeats and CRISPR-associated protein 9, is the most recent approach to genome 
editing which brings with it many new opportunities for biological advancement (“What Are 
Genome Editing and CRISPR-Cas9?”). It was developed from a naturally occurring gene editing 
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system used in bacteria as an immune system to kill viruses but was adapted for use in the lab. 
Using CRISPR, scientists do not have to engineer proteins as they would have with the older 
technologies called ZFN or TALEN. CRISPR has the ability to recognize specific genome 
sequences within a targeted DNA sequence using a short RNA strand matching the targeted area. 
Therefore, researchers only need to create the short synthetic sequences of RNA which is much 
easier to apply because DNA and RNA strands can bind together when they match. “The RNA 
portion of CRISPR, called a guide RNA, directs Cas9 enzyme to the targeted DNA sequence. 
Cas9 cuts the genome at this location to make the edit. CRISPR can make deletions in the 
genome and/or be engineered to insert new DNA sequences” (“How Does Genome Editing 
Work?”). Technology with the efficiency and affordability of CRISPR-Cas9 brings forth new 
potential in the prevention and treatment of diseases as well as the potential to enhance human 
traits. CRISPR-Cas9 could be vital to the prevention of single-gene disorders and complex 
diseases in somatic cells but is dangerous to be used for enhancing traits in germline cells and 
embryos. Because of this, laws should be enacted to limit the use of this technology beyond 
somatic cells. The research that has been conducted up to this point has been strictly used on 
somatic cells, so that the changes do not affect the future generations. This would prevent 
researchers from attempting to create a superior type of human being, much like Mary Shelley’s 
Victor attempted to do. Moral questions about creating a “designer baby” loom in the air due to 
the unknown danger of allowing parents to design their children like a doll in the American Girl 
store. Gene editing technologies also present danger in the labs of rogue governments, as they 
attempt to create superior races, either for military strength or ethnic cleansing.  
 There is limited research on CRISPR-Cas9 and its abilities due to the many ethical 
barriers that arise in response to this new type of technology. All around the world, there are 
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regulations that block scientists from experimenting with human embryos and germline cells. 
The research that has been conducted is strictly done with somatic cells. “Rudolf Janeisch, a 
biologist at the Massachusetts Institute of Technology, stated that any ‘attempts to edit human 
embryos [are] totally premature’” (Melillo 8). Experiments with somatic cells do not affect the 
future generations, and so if something doesn’t end up working out correctly, it would not affect 
the generations to follow. If one were to begin testing this new technology on human embryos, 
they could potentially be changing the future of a whole generation without even realizing it. The 
effects on the generations following gene-editing are unknown; therefore, it should not be legal 
to experiment with human embryos before more information is known. It is one thing to allow 
experimentation on a consenting person who knows the risks associated with it, but it is another 
thing to expose every generation following to the same risks with no way to reverse any damage. 
Through the discussion of additional benefits of CRISPR-Cas9 application, besides that of 
treating genetic diseases, it should be noted that, “Supporting these tremendous possibilities are a 
number of animal model studies as well as clinical trials using programmable nucleases that 
already provide important insights into the future development of Cas9-based therapeutics” (Hsu 
19). This sheds light on the fact that many of the perceived applications of this technology are 
hypothetical when discussed in relation to humans. Most of the experiments that have been done 
up to this point have been on animal cells due to the known and unknown dangers of testing on 
humans. “To determine with confidence whether it is exceptionally risky to involve humans in 
CRISPR translational and clinical research, possible research-related risks must be compared 
with those in other potentially dangerous experimental and every-day contexts. This is difficult, 
however, given that… robust, reliable data about CRISPR risk in human subjects are 
unavailable” (Brokowski 93). 
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 Giving parents the ability to choose specific traits about their children will bring new 
dangers as they begin to control more of their children’s lives. There are two big motivators 
when it comes to gene editing in embryos. One of the motivators is to prevent diseases in their 
children, and the other is to enhance certain traits that would help a child to excel in certain 
areas. When people have the option to avoid having a child with a predisposed disease, questions 
about which genetics should and should not be modified are asked. “Some critics argue that 
purposefully avoiding the implantation of embryos that are genetically predisposed to evolve into 
a child with a disability only perpetuates misconceptions that individuals with disabilities have a 
lesser quality of life” (Melillo 2). Once the idea of being born with a disease of any type is 
perceived as a misfortune, the stigma surrounding these types of things will only continue to get 
worse. It will actually make life harder for those individuals whose parents are unable to afford 
to pay for CRISPR technology which would allow them to prevent those diseases because of the 
way that people would view them. In addition to people carrying diseases, there are other traits 
that are genetically predisposed which could be “edited” or removed, but with these, there comes 
even more issues. It would be unethical for parents to be able to choose what their child should 
or should not be like physically, or mentally due to the fact that there is no “perfect standard” to 
follow, but rather the standards that every separate parent may hold. Ordering a baby as if it is a 
meal at a restaurant removes any sense of freedom or power from that human. In addition, 
creating a bunch of children to fit a standard of perfection would lead to a large decrease in 
diversity. If everyone looked the same and had the same level of abilities, then the possibilities of 
human endeavor may be limited. Furthermore, tweaking one gene to improve a particular ability 
may cause unforeseen issues for future generations as subtle changes in the genome sequences 
can have far reaching effects. “…it is unclear whether modified organisms will be affected 
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indefinitely and whether the edited genes will be transferred to future generations, potentially 
affecting them in unexpected ways” (Brokowski 90). This uncertainty should be enough to 
warrant a stop to the use of this “Frankenstein-esque” technology on human embryos. 
 Technologies with the ability to edit genes and potential to create a new race of superior 
humans, in the hands of a corrupt individual or government, could be detrimental to everyone. 
The idea of creating a superior human is not exactly new, and there are many examples through 
history which can attest to this fact. If the technology to create an ideal human was fully created 
and falls into the wrong hands, it could be used for nefarious reasons. Many researchers are 
worried that this new technology could bring about another attempt at the eugenics practices of 
the Holocaust or even the Sterilization Laws from the 1950s. In both of these instances, there 
were people who truly believed that they were performing their actions in order to better the 
human race, but in reality, these were discriminatory practices which brought harm to targeted 
groups of people. Once technology becomes available to detect when a child will be born with a 
genetic disease, many people want to take control and prevent that child from being born at all. It 
isn’t up to the law to decide who gets to be born and who doesn’t, this is how prejudices towards 
certain types of people are formed and why one person may feel that they are better than another. 
As soon as science begins to discriminate against certain diseases or disorders or disabilities, 
society will quickly turn on those who unable to help themselves. The focus of this technology 
should be on the sheer prevention or treatment of diseases that are dangerous to all rather than 
using to create the “ideal” human race.  
 In Mary Shelley’s Frankenstein, one of the major issues with the “birth” of the creature 
was that Victor’s world was not prepared for it. People will always be afraid of the unknown. 
Victor’s monster did not have a place in the society, and his future was threatening to the society 
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of the time. Genome editing must be limited in its scope in order to prevent the development of a 
race of misfits whose future is equally as threatening as Frankenstein’s “monster.” There is 
simply not enough information to allow scientists to begin testing on human embryos and 
germline cells, as the effects, positive, or more importantly, negative, could be seen in the 
generations to follow. It is unethical to allow the unknown risks fall on the next generations, 
leaving them with no way to reverse them. In addition, the rise of “designer babies” brings a 
whole new set of dangers and worries as the birth and conception of a child turns from 
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